Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1829814 | 0.88 | PAOX (0.43) | PAOXCYP2C19LMNAMEN1GLA | |
| SCHEMBL9170356 | 0.83 | ALDH1A1 (0.37) | PAOXCYP2C19ALDH1A1ALDH2LMNA | |
| SCHEMBL12444629 | 0.83 | LMNA (0.38) | PAOXCYP2C19ALDH1A1ALDH2LMNA | |
| SCHEMBL1450227 | 0.80 | PAOX (0.31) | PAOXALDH1A1ALDH2 | |
| SCHEMBL1832441 | 0.80 | PRMT3 (0.39) | PAOXALDH1A1ALDH2LMNACA12 | |
| SCHEMBL1835807 | 0.79 | ZDHHC20 (0.37) | CYP1A2 | |
| SCHEMBL24554276 | 0.78 | ALOX15 (0.39) | PAOXALDH1A1ALDH2LMNACA12 | |
| SCHEMBL9287610 | 0.78 | KDM4E (0.44) | PAOXALDH1A1TSHR | |
| SCHEMBL135270 | 0.78 | GAA (0.33) | CYP2C19ALDH1A1ALDH2LMNAMEN1 | |
| SCHEMBL15616382 | 0.77 | LMNA (0.36) | ALDH1A1ALDH2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331880-B3 | N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS | AUCENTRA THERAPEUTICS PTY LTD (AU) | 2023-01-11 | — | — | EP | disclosed |
| US-20130005696-A1 | BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2013-01-03 | — | — | US | disclosed |
| EP-2323144-A1 | Electrolytic capacitor | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | disclosed |
| EP-2323145-A1 | Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | disclosed |
| CN-100466122-C | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2009-03-04 | — | — | CN | disclosed |
| US-7397651-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-7295424-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| US-20070188979-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7227738-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-06-05 | — | — | US | disclosed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | disclosed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | disclosed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005696-A1 | BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF | CYP11B1, CYP51A1, U2AF1 | PAOX 1307/4885CYP2C19 47/4885ALDH1A1 731/4885 |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | AFF2, CACNA2D2, AFF4 | PAOX 3467/4885CYP2C19 4595/4885ALDH1A1 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.